
Melanotan I
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
Melanotan I (afamelanotide) is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) that selectively activates the melanocortin-1 receptor (MC1R) on pigment cells. It is a research tool for the biology of skin pigmentation.
| Test | Result | Status |
|---|---|---|
| Purity | 98.6% | Passed ✓ |
Research Information
Melanotan I is studied for MC1R-driven melanogenesis — the synthesis of protective eumelanin — and photoprotective pigmentation pathways in melanocyte models. Its receptor selectivity makes it useful for isolating MC1R signaling from the broader melanocortin system. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
Melanotan I Research & Studies
What is Melanotan I?
Melanotan I, also known as afamelanotide, is a synthetic peptide analog of the endogenous hormone α-melanocyte-stimulating hormone (α-MSH). It is employed in laboratory settings as a selective research tool for examining melanocortin-1 receptor (MC1R) biology and pigment-cell signaling. Investigators use Melanotan I to probe the molecular pathways that govern eumelanin synthesis in cultured melanocyte systems. The compound is supplied exclusively for in-vitro and controlled laboratory research applications.
Mechanism of Action
Melanotan I binds with high affinity to the melanocortin-1 receptor (MC1R) expressed on pigment-producing cells. Receptor engagement activates the Gs-protein–coupled cascade that elevates intracellular cyclic AMP, thereby stimulating tyrosinase expression and subsequent eumelanin production. Its structural modifications relative to native α-MSH confer greater receptor selectivity and metabolic stability in experimental media. This profile allows researchers to isolate MC1R-driven melanogenesis from broader melanocortin-system activity.
Primary Areas of Research
Laboratory studies focus on MC1R-mediated melanogenesis and the cellular programs that generate photoprotective eumelanin. Melanotan I is applied in melanocyte culture models to map downstream transcriptional networks, including MITF and related pigmentation genes. Investigators also examine how selective MC1R activation influences cellular responses to ultraviolet-mimetic stress in vitro. The peptide’s receptor specificity supports comparative work that distinguishes MC1R signaling from other melanocortin receptors.
Key Research Findings
In melanocyte and melanoma cell-line models, Melanotan I consistently elevates eumelanin content through MC1R-dependent cAMP elevation. Experimental data show increased expression of tyrosinase and other melanogenic enzymes following peptide exposure under controlled culture conditions. Studies further indicate that MC1R selectivity permits clearer attribution of observed pigmentation phenotypes to this single receptor pathway. These findings reinforce Melanotan I’s utility as a reference agonist for dissecting MC1R biology.
Research Handling & Considerations
Melanotan I is intended solely for in-vitro and laboratory research; it is not for human or animal consumption. Standard peptide-handling practices apply, including storage at recommended low temperatures and reconstitution in appropriate aqueous buffers. Researchers should verify peptide integrity by analytical methods before use in cell-based assays. All experimental work must comply with institutional biosafety and chemical-hygiene protocols.
Frequently Asked Questions
Melanotan I selectively activates the melanocortin-1 receptor (MC1R) on pigment cells, enabling focused study of MC1R-driven signaling pathways in vitro.
Explore Other High-Purity Peptides

GHK-Cu

AHK-Cu

SNAP-8
